BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)
$8.7 -0.76 (-8.0338%)
Analysed BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) News Sources
BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman
22-04-2026
yahoo.com
BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026
21-04-2026
yahoo.com
BBOT Granted U.S. FDA Fast Track Designation for BBO-11818 for the Treatment of Adult Patients with Advanced KRAS-Mutant Pancreatic Ductal Adenocarcinoma
20-04-2026
yahoo.com
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
13-04-2026
yahoo.com
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
18-03-2026
yahoo.com
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
16-03-2026
fool.com
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
16-03-2026
fool.com
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
16-03-2026
fool.com
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter
16-03-2026
fool.com
BridgeBio Oncology (BBOT) Spotlights Next-Gen RAS Pipeline, $425M Cash Runway Into 2028
13-03-2026
marketbeat.com
What is the current price of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The current price of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is $8.7.
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) absolute price change since previous trading day?
The absolute price change of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) since the previous trading day is $-0.76.
BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) percentage price change since previous trading day?
The percentage price change of BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) since the previous trading day is -8.0338%.
What is the most recent average sentiment score for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The most recent average sentiment score for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)?
The most recent sentiment for BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ) is .
SEC-8K** Filing Available For BRIDGEBIO ONCOLOGY THERAPEUT (BBOT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.